Retraction note {#Sec1}
===============

This article has been retracted by the authors after discovering an error in the data. The two CATIE-AD articles included in the systematic review \[[@CR1], [@CR2]\] should not have been treated as separate trials as this led to data from some trial participants being included twice in the meta-analysis. As a result, large sections of the article are inaccurate. To avoid confusion this article has been retracted and the authors have been given the opportunity to resubmit their corrected data.
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The online version of the original article can be found under doi:10.1186/s13195-015-0102-9.
